From the Journals

Statin use is uniformly low in adults with dyslipidemia disorders


 

FROM CIRCULATION

“Although rates of statin prescription have been steadily increasing over time, the rate of growth over the past decade has been slow, and there remains a significant gap in treatment rates,” wrote Dr. Bucholz and her colleagues. “Younger and uninsured adults with severe dyslipidemia in addition to those without a usual source of care are significantly less likely to be prescribed statins, highlighting the need for community-based interventions to target these adults with limited access to care.”

Apart from Sarah de Ferranti, MD, who receives research funding and royalties related to pediatric cardiology, no other authors had an relevant financial disclosures to report.

SOURCE: Bucholz EM et al. Circulation. 2018 Mar 23. doi: 10.1161/CIRCULATIONAHA.117.032321.

Pages

Recommended Reading

NASH rapidly overtaking hepatitis C as cause of liver cancer
MDedge Endocrinology
Overweight and obese individuals face greater cardiovascular morbidity
MDedge Endocrinology
Heart attacks soar in young IBD patients
MDedge Endocrinology
Post-ACS death lowered in ODYSSEY Outcomes
MDedge Endocrinology
ODYSSEY Outcomes results build on FOURIER
MDedge Endocrinology
ODYSSEY Outcomes trial redefines secondary cardiovascular prevention
MDedge Endocrinology
Interleukin-1 antagonist boosts testosterone in obese men
MDedge Endocrinology
VIDEO: Researchers closing in on the elusive ‘male pill’
MDedge Endocrinology
Red meat intake linked to NAFLD risk
MDedge Endocrinology
SGLT2 inhibitors cut cardiovascular outcomes regardless of region
MDedge Endocrinology